Risperidone safety in pregnancy. A case report.
The use of risperidone and other antipsychotic drugs during pregnancy is sometimes essential, although it is impossible to design clinical trials to demonstrate the safety of these kinds of drugs. The common method to communicate the absence of drug-related events is through case reports, even though they might be insufficient. This is a case report of a woman with a schizophreniform disorder who continued treatment with risperidone during all her pregnancy, and who gave birth to a healthy baby. The scientific evidence regarding risperidone safety during pregnancy is reviewed and the need to conduct followup studies evaluating the consequences of using antipsychotic drugs in pregnant women is stated.
Rodríguez-Salgado
B
B
Psychiatry Department, Centro de Salud Mental del Distrito de San Blas, Hospital Ramón y Cajal, Madrid, Spain. beatriz.rs@gmail.com
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D047109:Fetal Development / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D018967:Risperidone